Logotype for ViroGates

ViroGates (VIRO) investor relations material

ViroGates Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for ViroGates
Q3 2025 earnings summary10 Nov, 2025

Executive summary

  • Q3 2025 revenue increased 49% year-over-year, offsetting a weak Q2 and bringing nine-month revenue slightly above the same period in 2024.

  • Strategic focus shifted toward the longevity and general health market, leveraging suPAR as a biomarker for chronic inflammation and biological age assessment.

  • Business model evolving to a franchise approach, equipping partners with marketing and branding tools for broader market reach.

  • Company maintains presence in research and acute care, but development and sales efforts are increasingly directed at longevity.

  • Recurring customer base grew to 18, up from 16 at the end of Q3 2024.

Financial highlights

  • Q3 revenue increased 49% year-over-year; nine-month revenue reached DKK 3.5 million, up 4% from last year.

  • Operating expenses decreased by 10%, reducing operating loss by 21% to DKK 7.9 million.

  • Net loss decreased by 20% to DKK 7.96 million; cash and equivalents at DKK 9.1 million.

  • Gross profit for Q1–Q3 2025 was DKK 4.67 million, up 16% year-over-year.

  • Equity ratio dropped to 20% from 50% at Q3 2024 end.

Outlook and guidance

  • Full-year 2025 guidance maintained: revenue of DKK 5–7 million and EBIT of DKK -8 to -11 million.

  • Anticipates FDA de novo application for TurbiLatex product in Q1 next year, targeting a clinical claim for COVID.

  • EMA work ongoing to support Sobi’s drug Kineret, with IVDR authorization preparation underway.

  • Main US project with Sobi expected to complete in 2025, with revenue impact from 2026 onward.

  • Revenue mix expected to shift further toward longevity and general health segments over the next 2–3 years.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next ViroGates earnings date

Logotype for ViroGates
Q4 202521 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next ViroGates earnings date

Logotype for ViroGates
Q4 202521 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

ViroGates A/S is a medical technology company that develops and markets prognostic products for the healthcare sector. ViroGates offers Dynamis, a proprietary predictive model for estimating mortality in patients with severe sepsis in hospital, which can be used to trigger advanced solutions, improve patient monitoring, and evaluate interventions and clinical strategies.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage